Advertisement

Evidence for Altered Arachidonic Acid Metabolism in Tumor Metastasis

  • Paulette Mehta
Chapter
  • 20 Downloads
Part of the Developments in Oncology book series (DION, volume 22)

Abstract

The major challenge in the treatment of cancer is control of metastasis. In most instances, a tumor can be managed initially with chemotherapy, radiation therapy and/or surgery. In many cases, however, tumor cells escape from the primary site, traverse the vascular beds and may adhere to the vascular endothelium at distant sites. Subsequently growth and proliferation of the tumor occurs resulting in clinical metastasis. There is evidence that tumor cell-platelet-vessel wall interactions are important in the process of metastasis. Several platelet-, vessel wall- and tumor cell-generated prostaglandins (PG) are important in these interactions. The purpose of this paper is to review the current information on the role that these prostaglandins may have in the regulation of tumor metastasis (see also Chapter 14).

Keywords

Vessel Wall Platelet Aggregation Tumor Metastasis Bone Tumor Thrombotic Thrombocytopenic Purpura 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Weiss HJ. N. Engl. J. Med. 293: 531–580, 1975.Google Scholar
  2. 2.
    Honn KV, Cicone B and Skoff A. Science 212: 1270–1272, 1981.PubMedCrossRefGoogle Scholar
  3. 3.
    Wood S, Jr., Holyoke ED and Yardley JH. Proc. Can. Cancer Res. Gonf. 4: 167–223, 1961.Google Scholar
  4. 4.
    Wood S, Jr. Bull. Schweiz. Akad. Ifed. Wiss. 20: 92–121, 1964.Google Scholar
  5. 5.
    Warren BA and Vales O. Br. J. Exp. Pathol. 53: 301–313, 1972.PubMedGoogle Scholar
  6. 6.
    Jones DS, Wallace AC and Fraser EF. J. Natl. Cancer Inst. 46: 493–504, 1971.PubMedGoogle Scholar
  7. 7.
    Sindelar WF, Tralica TS and Ketcham AS. J. Surg. Res. 18: 137–161, 1975.PubMedCrossRefGoogle Scholar
  8. 8.
    Gasic GJ, Gasic TB, Galanti N, Johnson T and Murphy S. Int. J. Cancer 11: 704–718, 1973.PubMedCrossRefGoogle Scholar
  9. 9.
    Gasic G, Gasic T and Stewart CC. Proc. Natl. Acad. Sci. USA 61: 46–53, 1968.PubMedCrossRefGoogle Scholar
  10. 10.
    Hilgard P, Heller H and Schmidt CG. Z. Krebsforsch. 86: 243–250, 1976.CrossRefGoogle Scholar
  11. 11.
    Pearlstein E, Salk PL, Yogeeswaran G and Karpatkin S. Proc. Natl. Acad. Sci. USA 77: 4336–4339, 1980.PubMedCrossRefGoogle Scholar
  12. 12.
    Gasic GJ, Boettiger D, Catalfamo JL, Gasic TB and Stewart GJ. Cancer Kes. 38: 2950–2955, 1978.Google Scholar
  13. 13.
    Pearlstein E, Cooper LB and Karpatkin S. J. Lab. Clin. Med. 93: 332–334, 1979.Google Scholar
  14. 14.
    Honn KV, Cavanaugh P, Evens C, Taylor JD and Sloane BF. Science 217: 540–542,1982.PubMedCrossRefGoogle Scholar
  15. 15.
    Paul D, Niewiarowski S, Kodungallore GV, Rucinski B, Rucker S and Lange E. Proc. Natl. Acad. Sci. USA 77: 5914–5918, 1980.PubMedCrossRefGoogle Scholar
  16. 16.
    Nachman RL, Weksler B and Ferris B. Annu. Rev. Med. 30: 119–134, 1979.CrossRefGoogle Scholar
  17. 17.
    Holinsen H and Weiss HJ. Annu. Rev. Med. 30: 119–134, 1979.CrossRefGoogle Scholar
  18. 18.
    Kohler N and Upton A. Proc. Am. Assoc. Cancer Res. 18: 244A, 1977.Google Scholar
  19. 19.
    Cowan DH and Graham J. Froc. Am. Assoc. Cancer Res. 22: 56A, 1981.Google Scholar
  20. 20.
    Witoski E, Kapner N, Jefferson LS and Lipton A. Proc. Am. Assoc. Cancer Res. 22: 57A, 1981.Google Scholar
  21. 21.
    Moncada S and Vane JR. N. Engl. J. Med. 300: 1142–1147, 1979.PubMedCrossRefGoogle Scholar
  22. 22.
    Honn KV, Busse WD and Sloane BF. Biochem. Pharmacol. 32: 1–11, 1983.PubMedCrossRefGoogle Scholar
  23. 23.
    Bennett A, Berstock DA, Harris M, Raja B, Rove DJF, Stanford F ana Wright JE. Adv. Prostaglandin Thranbaxane Res. 6: 595–600, 1980.Google Scholar
  24. 24.
    Humes JL, Cupo JJ, Jr. and Strausser HR. Prostaglandins 6: 463–473, 1974.PubMedCrossRefGoogle Scholar
  25. 25.
    Jaffe BM, Philpott GW, Hampricht B and Parker CW. Adv. Biosci. 9: 179, 1973.Google Scholar
  26. 26.
    Bananarstrom S, Samuelsson B and Bjursel G. Nature (London) New Biol. 243: 50–51, 1973.Google Scholar
  27. 27.
    Gonzalez-Crussi F, Hsueh W and Wiederhold MD. Am. J. CLin. Pathol. 75: 24–253, 1981.Google Scholar
  28. 28.
    Fitzpatrick FA and Stringfellow DA. Proc. Natl. Acad. Sci. USA 76: 1765–1769, 1979.PubMedCrossRefGoogle Scholar
  29. 29.
    Chang WC, Muroto S and Tsurufuji S. Prostaglandins 13: 17–25, 1977.PubMedCrossRefGoogle Scholar
  30. 30.
    Honn KV, Meyer J, Neagos G, Henderson T, Westley C and Ratanatharathorn V. In: Interactions of Platelets and Timor Cells (Ed. Jamieson GA), Alan Liss, New York, pp. 295–331, 1982.Google Scholar
  31. 31.
    Tashjian AH, Jr., Voelkel EF, Levin L and Goldhaver P. J. Exp. Med. 136: 1329–1343, 1972.PubMedCrossRefGoogle Scholar
  32. 32.
    Powles TJ, CLark SA, Easty EM, Easty GC and Neville A. Br. J. Cancer 28: 316–321, 1973.PubMedCrossRefGoogle Scholar
  33. 33.
    Dowsett M, Easty GC, Powles TJ, Easty EM and Neville AM. Prostaglandins 11: 447–460, 1976.PubMedCrossRefGoogle Scholar
  34. 34.
    Honn KV and Meyer J. Biochem. Biophys. Res. Commun. 102: 1122–1129, 1981.PubMedCrossRefGoogle Scholar
  35. 35.
    Mehta P, Gross S and Ostrowski N. Am. J. Pediat. Hematol. Oncol, (in press),1983.Google Scholar
  36. 36.
    Mehta P, Springfield D and Ostrowski N. Cancer (Philadelphia) (in press), 1983.Google Scholar
  37. 37.
    Mehta P, Gross S, Ostrowski N and Brigmon L. Blood (Suppl): 218A, 1982.Google Scholar
  38. 38.
    Mshta P. Blood (in press), 1983.Google Scholar
  39. 39.
    Chen YC, McLeod B, Hall EE and Wu KK. Lancet 2: 267–269, 1981.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1984

Authors and Affiliations

  • Paulette Mehta

There are no affiliations available

Personalised recommendations